Synopsys (NASDAQ:SNPS) Stock: Insider Sassine Ghazi Sells 14,604 Shares

Synopsys, Inc. (NASDAQ:SNPS – Get Free Report) CEO Sassine Ghazi sold 14,604 shares of the business’s stock in a transaction on Thursday, October 15th. The stock was sold at an average price of $462.84, for a total value of $6,759,315.36. Following the sale, the chief executive officer owned 76,865 shares of the company’s stock, valued at approximately $35,576,196.60. The trade was a 15.97% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Sassine Ghazi also recently made the following trade(s):

  • On Tuesday, September 15th, Sassine Ghazi sold 14,604 shares of Synopsys stock. The shares were sold at an average price of $374.88, for a total value of $5,474,747.52.

Synopsys Trading Down 2.9%

Shares of NASDAQ SNPS traded down $13.48 during mid-day trading on Friday, hitting $454.63. The company’s stock had a trading volume of 2,515,910 shares, compared to its average volume of 2,058,492. The stock has a market cap of $87.12 billion, a price-to-earnings ratio of 80.32, a price-to-earnings-growth ratio of 1.96 and a beta of 1.21. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.34 and a quick ratio of 1.24. Synopsys, Inc. has a one year low of $362.55 and a one year high of $539.48. The company’s fifty day simple moving average is $426.79 and its 200-day simple moving average is $441.42.

Synopsys (NASDAQ:SNPS – Get Free Report) last released its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 EPS for the quarter, beating analysts’ consensus estimates of $3.67 by $0.24. Synopsys had a return on equity of 6.24% and a net margin of 11.43%. The business had revenue of $2.48 billion during the quarter, compared to the consensus estimate of $2.44 billion. During the same quarter in the prior year, the company posted $3.39 earnings per share. The firm’s revenue was up 42.4% on a year-over-year basis. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. On average, sell-side analysts anticipate that Synopsys, Inc. will post 10.97 earnings per share for the current fiscal year.

Synopsys announced that its Board of Directors has authorized a share repurchase plan on Monday, October 5th that permits the company to buy back $1.00 billion in shares. This repurchase authorization permits the semiconductor company to purchase up to 1.1% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s board of directors believes its stock is undervalued.

Wall Street Analyst Weigh In

SNPS has been the topic of several recent analyst reports. Roth Capital raised shares of Synopsys to a “buy” rating in a research note on Friday, September 25th. Morgan Stanley lowered their target price on shares of Synopsys from $525.00 to $500.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 19th. UBS Group set a $570.00 target price on shares of Synopsys in a research note on Thursday, August 27th. Sanford C. Bernstein began coverage on shares of Synopsys in a report on Friday, September 25th. They issued an “outperform” rating on the stock. Finally, Weiss Ratings cut shares of Synopsys from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, September 11th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $571.78.

Check Out Our Latest Report on SNPS

Institutional Investors Weigh In On Synopsys

Several large investors have recently made changes to their positions in the stock. BlackRock Inc. acquired a new position in Synopsys in the 2nd quarter worth $7,228,099,000. Van ECK Associates Corp raised its stake in shares of Synopsys by 19.7% in the 2nd quarter. Van ECK Associates Corp now owns 3,457,249 shares of the semiconductor company’s stock valued at $1,542,175,000 after purchasing an additional 569,687 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Synopsys by 40.7% in the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,087,349 shares of the semiconductor company’s stock valued at $1,377,174,000 after purchasing an additional 892,736 shares in the last quarter. Assenagon Asset Management S.A. lifted its holdings in shares of Synopsys by 11.2% in the third quarter. Assenagon Asset Management S.A. now owns 2,729,988 shares of the semiconductor company’s stock valued at $1,187,381,000 after purchasing an additional 274,586 shares in the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of Synopsys in the second quarter valued at about $747,400,000. Institutional investors own 85.47% of the company’s stock.

Synopsys Company Profile

(Get Free Report)

Synopsys, Inc is a technology company that develops electronic design automation (EDA) software, semiconductor intellectual property (IP), and software tools used to design, verify, and manufacture advanced electronic systems. Its solutions support the development of semiconductors, systems-on-chip, and electronic products across the design cycle, from initial specification and architecture through testing and production.

The company’s offerings include digital and custom integrated-circuit design tools, simulation and verification software, physical design and signoff products, and semiconductor IP such as processor cores, interface technologies, and foundational components.

See Also

Insider Buying and Selling by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.